U.S. Senate judiciary committee to hold hearing on ag chem deals

By 
Reuters
Reading Time: < 1 minute

Published: August 23, 2016

,

(Dave Bedard photo)

Washington | Reuters — The U.S. Senate judiciary committee will hold a hearing in late September to discuss the mergers of Dow Chemical and Dupont as well as ChemChina’s purchase of Syngenta, committee chair Charles Grassley said in a statement Tuesday.

Grassley, a Republican from the farm state of Iowa, has already expressed concern that the deals would result in farmers paying more for seeds, pesticides and herbicides and reduce the companies’ incentives to innovate.

“The seed and chemical industries are critical to agriculture and the nation’s economy, and Iowans are concerned that this sudden consolidation in the industry could cause rising input costs in an already declining agriculture economy,” Grassley said.

Read Also

Although commodity prices, such as those for wheat, have sharply increased due to the Middle East war, they haven’t spiked to the extent they did when Russia invaded Ukraine in 2022, with several limit up days. | Greg Berg file photo

CBOT Weekly: Gains in commodities amidst Iran conflict differ from Ukraine war

To analyst Tom Lilja of Progressive Ag in Fargo, N.D., there’s a difference in the commodity markets currently with the Middle East war and four years ago when Russia invaded Ukraine.

Dow and DuPont said in December that they would combine in an all-stock merger with plans to then break into three separate businesses. In February, China’s state-owned ChemChina made a US$43 billion bid for Swiss seeds and pesticides group Syngenta.

Executives from the companies will be invited to testify, as will consumer groups, the lawmaker said in a statement.

The committee has no formal say over whether the deals may go forward. The Justice Department is looking at the merger of Dow and DuPont, while the Federal Trade Commission is reviewing ChemChina’s purchase of Syngenta.

Reporting for Reuters by Diane Bartz.

About the author

Reuters

The news and media division of Thomson Reuters.

explore

Stories from our other publications